3B BlackBio Dx Limited Schedules Board Meeting for February 6, 2026 to Review Q3FY26 Financial Results

1 min read | Published on 30 Jan 2026, 04:09 PM |Updated on 30 Jan 2026, 04:09 PM

Reviewed by

Jubin VScanX News Team

Key Highlights

3B BlackBio Dx Limited has scheduled a board meeting for February 6, 2026, at 3:00 p.m. to consider and approve unaudited standalone and consolidated financial results for Q3FY26 and nine months ended December 31, 2025. The company has implemented trading window restrictions from January 1, 2026, until 48 hours after the results announcement, in compliance with SEBI insider trading regulations.

*this image is generated using AI for illustrative purposes only.

3b blackbio dx Limited has announced that its Board of Directors will convene on February 6, 2026, to review and approve the company's quarterly financial performance. The meeting represents a key milestone in the company's regulatory compliance and investor communication process.

Board Meeting Details

The board meeting has been scheduled with specific parameters to ensure proper governance and regulatory adherence:

Parameter:	Details
Meeting Date:	Friday, February 6, 2026
Meeting Time:	3:00 p.m.
Venue:	Registered office of the company
Purpose:	Consider and approve Q3FY26 financial results
Reporting Period:	Quarter and nine months ended December 31, 2025

Financial Results Scope

The board will review comprehensive financial statements covering multiple aspects of the company's performance. The meeting agenda includes consideration and approval of both unaudited standalone and consolidated financial results for the specified period. This dual approach provides stakeholders with a complete view of the company's financial position, including subsidiary performance and standalone operations.

Trading Window Restrictions

In compliance with SEBI regulations regarding insider trading, 3B BlackBio Dx Limited has implemented trading window restrictions to maintain market integrity:

Restriction Details:	Timeline
Trading Window Closure Start:	January 1, 2026
Results Announcement:	February 6, 2026
Trading Window Reopening:	48 hours after results announcement
Applicable Securities:	Company's Equity Shares

Regulatory Compliance

The board meeting announcement fulfills the company's obligations under Regulation 29(1) and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally notified BSE Limited through its Department of Corporate Relations, ensuring proper disclosure to market participants and regulatory authorities.

The communication was signed by Nikhil Kuber Dubey, Whole Time Director, demonstrating appropriate corporate governance and executive oversight in the disclosure process.

Historical Stock Returns for 3B BlackBio DX